Non-canonical and induced neoantigens as emerging sources of cancer-specific immunotherapy targets - Top-Institutions - MDSpire

Non-canonical and induced neoantigens as emerging sources of cancer-specific immunotherapy targets

  • By

  • Viacheslav V. Kudriavskii

  • Valeriia A. Koss

  • Victoria O. Shender

  • Georgij P. Arapidi

  • July 2, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Oncology

  • #2

    Broad Institute
    Broad Institute

    Cambridge, MA

    Key Differentiators

    • Genomics
    • Oncology

  • #3

    Rutgers Cancer Institute of New Jersey
    Rutgers Cancer Institute of New Jersey

    New Brunswick, NJ

    Key Differentiators

    • Oncology

  • #4

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Oncology

  • #5

    Vanderbilt University
    Vanderbilt University

    Nashville, TN

    Key Differentiators

    • Oncology

Original Source(s)

Non-canonical and induced neoantigens as emerging sources of cancer-specific immunotherapy targets

  • by Viacheslav V. Kudriavskii, Valeriia A. Koss, Victoria O. Shender, Georgij P. Arapidi

  • July 2, 2026

Related Content

Microbiome dysbiosis and its modulation in cancer development, prevention and therapy

SNAP Participation and Cancer Screening for Adults With Food Insecurity

Crucial role of IL-6, IL-8, IL-11 and leptin in tumor microenvironment in a group of patients with GEP-NETs- crosstalk between inflammation and cancer